About CollabRx
CollabRx, Inc. was a company that offered cloud-based expert systems for selecting clinical treatments for molecular diseases such as cancer. Its technology revolved around dynamically updated molecular disease models that form the basis of the expert systems. One of the challenges evolving from the recent explosion in biological information is to distill actionable clinically relevant therapy approaches from the vast amount of data available. The knowledgebases that inform the models were updated by a large network of advisors from academic and medical institutions.
Access to the expert systems was offered under software-as-a-service contracts. A major user of the technology was expected to be DNA testing laboratories which hope to translate patient-specific genetic characterization to patient-specific clinical treatment advice for molecular diseases.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
CollabRx timeline
- 2008
- 🏁Founded
Events of CollabRx from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
More about CollabRx
- Acquisitions and changes
- No longer listed: ticker CLRX is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).
Market cap history
Not enough history yet.
Sources and freshness
- Profile updated:
- Nov 14, 2026
Figures from Wikidata, Wikipedia, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at CollabRx? Verify and update this profile — free
Show CollabRx's ranking on your website Get the badge
The badge updates itself as the ranking changes.